ExLibris header image
SFX Logo
Title: Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics
Source:

Pharmacogenomics Journal [1470-269X] Nikoloff, D yr:2002


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Ohmori, O. "Tardive dyskinesia and debrisoquine 4-hydroxylase (CYP2D6) genotype in Japanese schizophrenics." Schizophrenia research (1998): 107-113. Link to Full Text for this item Link to SFX for this item
2. Patsopoulos, Nikolaos A. "CYP2D6 polymorphisms and the risk of tardive dyskinesia in schizophrenia: a meta-analysis." Pharmacogenetics and genomics 15.3 (2005): 151-158. Link to SFX for this item
3. Kapitany, T., T. "Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia." Schizophrenia Research 32.2 (1998): 101-106. Link to Full Text for this item Link to SFX for this item
4. Topić, E. "CYP2D6 genotyping in patients on psychoactive drug therapy." Clinical chemistry and laboratory medicine 38.9 (2000): 921-927. Link to SFX for this item
5. RA, R. "Open forum: effectiveness versus efficacy of second-generation antipsychotics: haloperidol without anticholinergics as a comparator." Psychiatric Services 56.1 (2005): 85-92. Link to SFX for this item
6. Beszłej, J A A. "[The importance of examining genetic polymorphism of drug oxidation in psychiatry]." Psychiatria polska (1995): 45-56. Link to SFX for this item
7. Jaanson, P. "Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype." Psychopharmacology 162.1 (2002): 67-73. Link to Full Text for this item Link to SFX for this item
8. Tiwari, B K K. "Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C > T polymorphism." The pharmacogenomics journal 7.5 (2007): 305-311. Link to Full Text for this item Link to SFX for this item
9. Bertilsson, L. "Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs." British journal of clinical pharmacology 53.2 (2002): 111-122. Link to Full Text for this item Link to SFX for this item
10. Schillevoort, I. "Antipsychotic-induced extrapyramidal syndromes and cytochrome P450 2D6 genotype: a case-control study." Pharmacogenetics 12.3 (2002): 235-40. Link to SFX for this item
11. Lachman, H. "A strategy for identifying phenotypic subtypes: Concordance of symptom dimensions between sibling pairs who met screening criteria for a genetic linkage study of childhood-onset bipolar disorder using the Child Bipolar Questionnaire." Journal of Affective Disorders 99.1 (2007): 27-36. Link to SFX for this item
12. Zai, C. C. "Meta-analysis of two dopamine D-sub-2 receptor gene polymorphisms with tardive dyskinesia in schizophrenia patients." Molecular psychiatry 12.9: 794-5. Link to SFX for this item
13. Chen Y, Y. "Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study." The Annals of pharmacotherapy 42.2 (2008): 177-184. Link to SFX for this item
14. Scordo, M G G. "CYP2D6 genotype and antipsychotic-induced extrapyramidal side effects in schizophrenic patients." European journal of clinical pharmacology 56.9-10 (2001): 679-83. Link to Full Text for this item Link to SFX for this item
15. Yates, Mark R. "Letter to the editor: Concurrent tracking of alcohol use and bipolar disorder symptoms." Bipolar disorders 9.7 (2007): 789-790. Link to Full Text for this item Link to SFX for this item
16. Raghunandan, V. P. "Is bipolar II disorder misdiagnosed as major depressive disorder in children?" Journal of Affective Disorders 98.3 (2007): 263-266. Link to SFX for this item
17. Thode, Eric S. "The child bipolar questionnaire: A dimensional approach to screening for pediatric bipolar disorder." Journal of affective disorders 95.1-3 (2006): 149-3. Link to SFX for this item
18. Bolla, E. "Are CYP1A2*1F and *1C associated with clozapine tolerability?: a preliminary investigation." Psychiatry research 189.3 (2011): 483-483. Link to SFX for this item
19. Desmarais, Julie E. "Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment?" Journal of psychopharmacology 26.9 (2012): 1167-74. Link to Full Text for this item Link to SFX for this item
20. Kumar, A. "Zuclopenthixol Dihydrochloride for schizophrenia." Schizophrenia Bulletin 35.5 (2009): 855-856. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.